Inactivation Of Cbl-b Can Obviate The Requirement For CD28 Costimulation Of T Cells In Tumor Rejection
Technology
E-153-2009
Patent ID
E-153-2009-0-US-18
Country
US
Application Type
CON
Patent Status
Issued
Patent Number
10822588
Publication Number
US-2020-0190472-A1
Application Number
16/579,583
IC
NCI
Date Filed
Date Issued